Mount Sinai Kicks Off Education and Support Program for Prostate Cancer Patients
The Mount Sinai Medical Center has partnered with the American Cancer Society to start a new program called "Man to Man: Prostate Cancer Education and Support Meetings for Survivors and Families."
The Mount Sinai Medical Center has partnered with the American Cancer Society to start a new program called "Man to Man: Prostate Cancer Education and Support Meetings for Survivors and Families." The program will take place six times per year and will feature various Mount Sinai prostate cancer specialists who will discuss prostate cancer and treatment options, including robotic prostate surgery and bloodless prostate surgery with men and their families. After the presentations, a prostate cancer survivor leads a confidential support group where everyone is welcome to share their experiences and common problems.
This program is open to men with an elevated PSA or newly diagnosed prostate cancer. Dr. David B. Samadi, MD, Chief of Robotics and Minimally Invasive Surgery in the Department of Urology at Mount Sinai, presented the first lecture on the Da Vinci Robotic Prostatectomy procedure on January 14. "We hope the Man to Man program will be a place where patients can learn about their options after diagnosis of prostate cancer, from robotic prostatectomy to radiation. Also, they may be dealing with other issues such as incontinence and sexual function. This program is designed to help men and their families cope with the road ahead of them," said Dr. Samadi.
Man to Man Program Schedule
March 17, 2009 6-8PM
Do I Have To Be Treated? Update on Expectant Management
Simon Hall, MD
Mount Sinai School of Medicine
Hatch Auditorium-1468 Madison Ave Guggenheim Pavilion 2nd Floor
May 19, 2009 6-8PM
Update On Prostate Brachytherapy
Richard Stock, MD
Mount Sinai School of Medicine
Hatch Auditorium- 1468 Madison Ave Guggenheim Pavilion 2nd Floor
About David B. Samadi, MD
David B. Samadi, MD, is a board-certified urologic surgeon trained in open, laparoscopic, and robotic surgery. He is one of the world's most experienced da Vinci surgeons with a professionally acknowledged level of success. Dr. Samadi is one of the only surgeons in the country to have completed two fellowships: one in oncology at Memorial Sloan Kettering Cancer Center in New York, and the other in laparoscopy at Henri Mondor Hospital in France.
Dr. Samadi has completed more than 1,600 da Vinci cases in his career thus far. Since his arrival at Mt. Sinai a year ago, he has performed over 750 robotic operations. Dr. Samadi has proctored and taught urologists all over the world how to perform the endopelvic fascia sparing robotic prostatectomy procedure. Dr. Samadi's robotic surgery program at Mount Sinai is unique in its ability to combine the advanced technology of robotics with the expertise of open and laparoscopic surgery. To contact Dr. David Samadi, please call 1-888-Robot10 (1-888-762-6810), or visit his website: www.RoboticOncology.com.
About The Mount Sinai Medical Center
The Mount Sinai Medical Center encompasses The Mount Sinai Hospital and Mount Sinai School of Medicine. The Mount Sinai Hospital is one of the nation’s oldest, largest and most-respected voluntary hospitals. Founded in 1852, Mount Sinai today is a 1,171-bed tertiary-care teaching facility that is internationally acclaimed for excellence in clinical care. Last year, nearly 50,000 people were treated at Mount Sinai as inpatients, and there were nearly 450,000 outpatient visits to the Medical Center.
Mount Sinai School of Medicine is internationally recognized as a leader in groundbreaking clinical and basic-science research, as well as having an innovative approach to medical education. With a faculty of more than 3,400 in 38 clinical and basic science departments and centers, Mount Sinai ranks among the top 20 medical schools in receipt of National Institute of Health (NIH) grants.